Janusz Siebert
Overview
Explore the profile of Janusz Siebert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
734
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Piotrowicz K, Krzesinski P, Galas A, Stanczyk A, Siebert J, Jankowska E, et al.
Front Public Health
. 2024 Oct;
12():1431778.
PMID: 39391161
Introduction: The growing population of heart failure (HF) patients places a burden on the healthcare system. Patient-centered outcomes such as health-related quality of life (HRQoL) and self-care behaviors are key...
2.
Redlarski G, Koziel S, Krawczuk M, Siebert J, Talalaj M, Palkowski A, et al.
Int J Occup Med Environ Health
. 2024 Apr;
37(2):205-219.
PMID: 38634421
Objectives: Body surface area (BSA) is one of the major parameters used in several medical fields. However, there are concerns raised about its usefulness, mostly due to the ambiguity of...
3.
Zielinski M, Sakowska J, Iwaszkiewicz-Grzes D, Gliwinski M, Hennig M, Zalinska M, et al.
Int Immunopharmacol
. 2024 Mar;
132:111919.
PMID: 38554443
An imbalance between exaggerated autoaggressive T cell responses, primarily CD8 + T cells, and impaired tolerogenic mechanisms underlie the development of type 1 diabetes mellitus. Disease-modifying strategies, particularly immunotherapy focusing...
4.
Zakrzewska A, Biedunkiewicz J, Komorniczak M, Jankowska M, Jasiulewicz K, Plonka N, et al.
J Clin Med
. 2024 Jan;
13(2).
PMID: 38256460
There are several forms of maintenance high-efficiency hemodialysis (HD), including hemodiafiltrations (HDF) in different technical modes and expanded HD, using dialyzers with medium cut-off membranes. The aim of the study...
5.
Trzeciak B, Kowalczyk W, Grymek S, Gutknecht P, Siebert J
Int J Occup Med Environ Health
. 2023 Nov;
36(5):656-671.
PMID: 37962060
Objectives: Employees of uniformed services (EoUS) were screened for cardiovascular risk factors. Material And Methods: A total of 1138 EoUS (age M±SD 49.9±6.0 years) and 263 controls (age M±SD 54.4±9.7...
6.
Kordalewska M, Wawrzyniak R, Jacyna J, Godzien J, Lopez Gonzalves A, Raczak-Gutknecht J, et al.
Biochem Biophys Rep
. 2022 Aug;
31:101318.
PMID: 35967759
Renal cell carcinoma (RCC) is a disease with no specific diagnostic method or treatment. Thus, the evaluation of novel diagnostic tools or treatment possibilities is essential. In this study, a...
7.
Trzeciak B, Gutknecht P, Marek-Trzonkowska N, Molisz A, Czaja R, Siebert J
Ann Agric Environ Med
. 2022 Jun;
29(2):264-268.
PMID: 35767761
Introduction And Objective: Difficult-to-control blood pressure can be attributed to a mismatch between the haemodynamic type of hypertension and the drug class used in treatment. Impedance cardiography may be a...
8.
Zielinski M, Zalinska M, Iwaszkiewicz-Grzes D, Gliwinski M, Hennig M, Jazwinska-Curyllo A, et al.
Diabetes Obes Metab
. 2022 Apr;
24(8):1534-1543.
PMID: 35441440
Aims: Monotherapy with autologous expanded CD4 CD25 CD127 T regulatory cells (Tregs) or rituximab has been documented to slow disease progression in patients with recent-onset type 1 diabetes mellitus (T1DM)....
9.
Piekarska K, Urban-Wojciuk Z, Kurkowiak M, Pelikant-Malecka I, Schumacher A, Sakowska J, et al.
Nat Commun
. 2022 Feb;
13(1):856.
PMID: 35165293
Cell-based immunotherapies can provide safe and effective treatments for various disorders including autoimmunity, cancer, and excessive proinflammatory events in sepsis or viral infections. However, to achieve this goal there is...
10.
Krzesinski P, Jankowska E, Siebert J, Galas A, Piotrowicz K, Stanczyk A, et al.
Eur J Heart Fail
. 2021 Oct;
24(3):565-577.
PMID: 34617373
Aim: Prevention of heart failure (HF) hospitalisations and deaths constitutes a major therapeutic aim in patients with HF. The role of telemedicine in this context remains equivocal. We investigated whether...